High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer

Abstract

Our results demonstrated the association of Aurora-B with chemoresistance in NSCLC, which may finally contribute to the poor prognosis of NSCLC patients. We also suggested Aurora-B as a promising therapeutic target in NSCLC treatment.